Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mohamad Fekredeen Ayas"'
Publikováno v:
BMJ Open Gastroenterology, Vol 8, Iss 1 (2021)
Background Hepatic encephalopathy (HE) is defined as brain dysfunction that occurs because of acute liver failure or liver cirrhosis and is associated with significant morbidity and mortality. Lactulose is the standard of care till this date; however
Externí odkaz:
https://doaj.org/article/e287e68ec6964a579c7314f8a00c88aa
Publikováno v:
European Journal of Case Reports in Internal Medicine (2020)
Extraintestinal manifestations of Crohn's disease sometimes occur and can present prior to intestinal symptoms. Ocular manifestations of Crohn's disease are considered rare, with orbital myositis an even rarer manifestation with only a handful of cas
Externí odkaz:
https://doaj.org/article/3830810b58d148998e10407ced199985
Autor:
Abdullah Al-Jefri, Hawazen Al-Saedi, Awatif Alanazi, Amal Al-Seraihi, Rafat Jafri, Mouhab Ayas, Mohamad Fekredeen Ayas, Ali Al-Ahmari, Ibrahim Ghemlas, Khawar Siddiqui
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:2217-2221
Allogeneic hematopoietic cell transplantation (HCT) has been shown to restore normal hematopoiesis in patients with Fanconi anemia (FA), with excellent results in matched related donor HCT. Outcomes of alternative donor HCT are less favorable, howeve
Autor:
Marie-Annick Clavel, Brigitte E. Kazzi, Bahaa M. Fadel, Dania Mohty, Khadija Alassas, Philippe Pibarot, Mohamad Fekredeen Ayas
Publikováno v:
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 35(2)
Background There is a lack of comprehensive echocardiographic data to allow discrimination of normal versus abnormal mechanical prosthetic tricuspid valve (MPTV) leaflet function. The identification of such parameters is essential to optimize diagnos
Autor:
Mouhab Ayas, Mohamad Fekredeen Ayas, Amal Al-Agil, Ibrahim Ghemlas, Ali Al-Ahmari, Amal Al-Seraihi
Publikováno v:
Pediatric Blood & Cancer. 65:e27371
Hematopoietic cell transplantation (HCT) remains until now the only curative modality for hematological manifestations in patients with Fanconi anemia (FA). The doses of alkylating agents used in the conditioning of this patient population before HCT